The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis | Zendy

Timothy W. Smith | Zendy; Luc Jordaens | Zendy; Damj Theuns | Zendy; Pascal F. van Dessel | Zendy; Arthur A.M. Wilde | Zendy; M. G. Myriam Hunink | Zendy

Open Access

The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis

Author(s) -

Timothy W. Smith,

Luc Jordaens,

Damj Theuns,

Pascal F. van Dessel,

Arthur A.M. Wilde,

M. G. Myriam Hunink

Publication year - 2012

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehs090

Subject(s) - medicine , ischaemic heart disease , implantable cardioverter defibrillator , cardiology , ejection fraction , ischaemic stroke , primary prevention , cohort , disease , heart disease , intensive care medicine , ischemia , heart failure

It remains unclear whether primary prophylactic implantable cardioverter-defibrillator (ICD) therapy is cost-effective compared with a 'no ICD strategy' in the European health care setting. We performed a cost-effectiveness analysis for a cohort of patients with a left ventricular ejection fraction <40% and ischaemic or non-ischaemic heart disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research